HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ende... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Exe... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 20... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2017, aft... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2017, filed w... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and fiscal year en... more »
HAWTHORNE, N.Y.--(EON: Enhanced Online News)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the fiscal year ended March 31, 2017... more »
Contact Us
For more information, visit the Contact Us page of BusinessWire.com to find a bureau near you.